Details for Patent: 10,835,499

Which drugs does patent 10,835,499 protect, and when does it expire?

Patent 10,835,499 protects ADLARITY and is included in one NDA.

This patent has fifteen patent family members in eleven countries.

Summary for Patent: 10,835,499

Title:	Systems and methods for long term transdermal administration
Abstract:	Devices, systems, compositions and methods for long term or prolonged transdermal administration of an active agent are provided.
Inventor(s):	Lee; Eun Soo (Redwood City, CA), Jain; Amit K. (Milpitas, CA), Singh; Parminder (Union City, CA)
Assignee:	Corium, Inc. (Menlo Park, CA)
Application Number:	15/396,252
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 10,835,499

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Corium	ADLARITY	donepezil hydrochloride	SYSTEM;TRANSDERMAL	212304-001	Mar 11, 2022		RX	Yes	No			Y			A METHOD OF TRANSDERMAL DELIVERY OF DONEPEZIL FOR TREATING MILD, MODERATE AND SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE
Corium	ADLARITY	donepezil hydrochloride	SYSTEM;TRANSDERMAL	212304-002	Mar 11, 2022		RX	Yes	Yes			Y			A METHOD OF TRANSDERMAL DELIVERY OF DONEPEZIL FOR TREATING MILD, MODERATE AND SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE

International Family Members for US Patent 10,835,499

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2016381351
Australia	2022235539
Canada	3010183
China	108697655
European Patent Office	3397250